Torrent Pharmaceuticals files SEBI Regulation 31(4) disclosure for substantial acquisition in JB Chemicals

M&A / JV 1 Jul 2026 · Filed / open· ✓ Verified

The NSE filing reference (team_sandeshc_24062026122536_42.pdf, dated 24 Jun 2026) is a Regulation 31(4) disclosure submitted by Torrent Pharmaceuticals to the exchange. This regulation mandates disclosure within one trading day of acquisition or agreement to acquire substantial shares or control. The absence of parallel company press releases or exchange announcements from either party suggests this may be an early-stage filing, and substantive deal terms remain undisclosed in the public domain.

Why it mattersRegulation 31(4) disclosure is mandatory when a party acquires 25% or more of shares or voting rights, or gains control; the filing indicates a structural threshold has been crossed but lacks public detail on structure, price, and conditions.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals